Document Detail


A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients.
MedLine Citation:
PMID:  21592635     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Botulinum toxin is commonly used to treat spastic equinus foot. This treatment seems to improve gait in hemiplegic patients when used alone or combined with an ankle-foot orthosis. However, the nature and effects of this improvement have until now rarely been studied. The aim of this study was to quantify the impact of a Botulinum toxin injection in the triceps surae of hemiplegic patients with equinus foot, used either alone or in combination with an ankle-foot orthosis, on the kinematics and dynamics of the paretic lower limb, and to determine the advantage of combining an ankle-foot orthosis with this pharmacological treatment. METHODS: Patients were assessed using gait analysis to measure spatio-temporal, kinematic and dynamic parameters of the gait cycle before Botulinum toxin injection and then 3 and 6weeks after injection. Eight chronic hemiplegics following central nervous system lesion were included. FINDINGS: Botulinum toxin injection led to an increase in velocity, peak ankle dorsiflexion during stance phase, and peak knee flexion during swing phase. It also resulted in an increased peak plantarflexion moment. Use of ankle-foot orthosis led to a specific increase in peak ankle dorsiflexion during swing phase and also increased peak plantarflexion moment. INTERPRETATION: The results indicate that combined Botulinum toxin injection of the triceps surae and wearing an ankle-foot orthosis is more effective than the use of Botulinum toxin only. Use of an ankle-foot orthosis increases ankle dorsiflexion during the swing phase and does not reduce the benefits gained by the use of Botulinum toxin in stance phase.
Authors:
Didier Pradon; Emilie Hutin; Simon Khadir; Redha Taiar; François Genet; Nicolas Roche
Related Documents :
2105115 - Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazo...
388085 - The value of prophylactic antibiotics in aorat-coronary bypass operations: a double-bli...
17855185 - Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and ...
850085 - Incidence of diarrhea and colitis associated with clindamycin therapy.
25012055 - Tragal cartilage shield tympanoplasty: our technique and results in 612 cases.
2951815 - Long-term treatment with 'duovent' in elderly patients affected by chronic obstructive ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-16
Journal Detail:
Title:  Clinical biomechanics (Bristol, Avon)     Volume:  -     ISSN:  1879-1271     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8611877     Medline TA:  Clin Biomech (Bristol, Avon)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
Laboratoire d'Analyse du Mouvement, EA 4497, CIC-IT 805, AP-HP, CHU Raymond Poincaré, Garches, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  What do midwives think about interprofessional working and learning?
Next Document:  Pyrethroid insecticides in urban salmon streams of the Pacific Northwest.